Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities ...
Jun 24, 2024
0
26
Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer ...
Jun 19, 2024
0
35
When low doses of cancer drugs are administered continuously near malignant brain tumors using so-called iontronic technology, cancer cell growth drastically decreases. Researchers at Linköping University, Sweden, and the ...
Jun 19, 2024
0
1
Within each of our cells, long strands of DNA are folded into chromosomes and capped with protective structures called telomeres. But telomeres shorten as we age, eventually getting so whittled down that our chromosomes become ...
Jun 19, 2024
0
33
Human papillomavirus (HPV) is a pivotal etiological factor in the development of several cancers, with a profound impact on global public health. It is estimated that 50–70% of sexually active individuals are infected with ...
Jun 17, 2024
0
0
Focusing on four common diseases—diabetes, heart disease, depression and bowel cancer—new Flinders University research provides insights into the importance of a healthy microbiome balance in the human gut and in the ...
Jun 17, 2024
0
0
Scientists at the University of Southern California have developed an artificial intelligence (AI)-powered system to track tiny devices that monitor markers of disease in the gut. Devices using the novel system may help at-risk ...
Jun 12, 2024
0
44
In a new UCLA-led study, investigators shed light on the intricate processes underlying cancer evolution and define the optimal algorithms to analyze the genetic makeup of tumors.
Jun 11, 2024
0
7
Implementing human papillomavirus (HPV)-based screening in British Columbia could eliminate cervical cancer in the province before 2040, according to a modeling study in the Canadian Medical Association Journal (CMAJ).
Jun 3, 2024
0
0
Graduate student Hillary Layden studies transcriptional control of cancer in the lab of Scott Hiebert, Hortense B. Ingram Chair in Cancer Research and professor of biochemistry.
May 30, 2024
0
0
